Doxazosin
Product Images NDC 50090-4000

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 50090-4000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin Tablets, Usp (A308818e E36c 4431 Bf51 274650c38cb0 01)

Chemical structure of doxazosin mesylate, showing its molecular configuration with multiple aromatic rings, nitrogen-containing heterocycles, and methoxy functional groups, along with the mesylate (CH3SO3H) component.*

FDA Label Image

Doxazosin Tablets (A308818e E36c 4431 Bf51 274650c38cb0 02)

This image presents data on symptom score and maximum flow rate from clinical studies evaluating doxazosin doses versus placebo. It includes mean baseline values and changes for symptom score and flow rate in three studies with varying dose titrations, showing statistical significance levels. A bar graph compares maximum flow rate changes in Study 2 between placebo, 4 mg, and 8 mg doxazosin groups.*

FDA Label Image

Doxazosin Tablets, Usp (A308818e E36c 4431 Bf51 274650c38cb0 03)

Two line graphs comparing Doxazosin and placebo over 14 weeks. The left graph shows the mean change in total symptom score from baseline, with Doxazosin showing a greater decrease than placebo. The right graph shows the mean increase in maximum urinary flow rate (mL/sec) from baseline, with Doxazosin showing a greater increase than placebo. Both graphs include sample sizes (N=50 for Doxazosin, N=47 for placebo) and indicate statistical significance.*

FDA Label Image

Label Image (Lbl500904000)

Label for Doxazosin 8 mg tablets by A-S Medication Solutions showing NDC 50090-4000-0. The label states the active ingredient as Doxazosin with an equivalent amount of Doxazosin Mesylate 16.79 mg per tablet. The packaging contains 30 tablets and advises storage at 68 to 77 degrees Fahrenheit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.